FDA Investigator Lakisha M Williams

Lakisha M Williams has conducted inspections on 30 sites in 1 countries as of 28 Nov 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
30
Last Inspection Date:
28 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Lakisha M Williams:
Alicia M Mozzachio, Althea A Williams, Amanda B Athey, Amanda Dinaro, Amanda S Zorn, Amber G Chung, Ana P Barido, Andrea A Branche, Andrea George, PhD, Andrew J Howard, Angel K Sandhu, Angela L Hatzenbuhler, Anh M Lac, Anna Flynn, Arianne L Motter, Arindam Dasgupta, PhD, Ashley M Whitehurst, Austin B Appler, Barbara A Burke, Barbara A Gullick, Barbara J Holladay, Barbara J Wilcox, PhD, Barbara Janine Breithaupt, Brandon L Mariner, Brian D Nicholson, Brian R Yaun, Brooke K Higgins, Bruce H Mccullough, Byungja E Marciante, Calvin B Koerner, Carl Lee, Carole L Jones, Carrie Ann Plucinski, Cecil D Mitchell, Chad E Schmear, Chaltu Nwakijra, Charles A Snipes, PhD, Charles D Boison, Charles E Idjagboro, Charles M Kerns, BLT DO, Charles R Bonapace, PhD, Chiang Syin, PhD, Christian D Lynch (CDL), Christine M Whitby, CSO, Christine W Twohy, Christopher R Czajka, Clarice J Ahn, Courtney N Long, Creighton T Tuzon, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Daniel C Kearns, Daniel J Roberts, Daniel Kearns, Daniel R Azar, David K Glasgow, David L Chon, David P Rice, Jr, Dawn M Collins, Debra Bower, Debra I Love, Debra Lboyd Seale, Dolores Harper, Douglas A Campbell, Dr. Guang Gao, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin R Abaonza, Edette J Newby, Edward P Potter, Ellen A Humphrey, Elliot P Cowam, PhD, Elvis D Morton, Emest F Bizjak, Emily Shacter, Eric L Dong, BS, Eric M Mueller, PharmD, Erin L Mcfiren, Erin M Mcdowell, Gabrielle J Swain, Gail L Katz, Gale L Glinecki, Gene D Arcy, Gerald Feldman, Gerald M Feldman, PhD, Heath R Harley, Helen B Ricalde, Henry K Lau, Holly S Simms, Humera T Khan, Jacqueline Mdiaz Albertini, Jai P Singh, James R Evans, James T Mccoy, James W Leonette, James W Plucinski, Jamie D Swann, Jan B Welch, Jason F Chancey, Jeanne D Shaffer, Jeanne Fringer, PhD, Jeanne M Morris, Jeffrey A Reed, Jeffrey M Watson, Jesse A Vazquez, Jessica D Nanini, Jessica D Weber, Joan A Loreng, Joan T Briones, Joey V Quitania, John A Kadavil, PhD, John Dan, John M Gusto, Johnson, Jonathan W Chapman, Joseph A Morkunas, Joseph Kutze, PhD, Joseph P Iser, MD, Joseph W Matthews, Joshua S Hunt, Julie A Silberberg, Julie D Bringger, Jyoti B Patel, PhD, Karen A Spencer, Karen Emasley Joseph, Kathleen B Swat, Kenneth Nieves, Kevin P Foley, Kimberly Lewandowski Walker, Kujtim Sadiku, Kurt A Brorson, PhD, La Tasham Gunter, Lance Mde Souza, MBA, Laurie A Haxel, Laurie P Norwood, Laurissa S Flowers, LCDR Jennifer H Rhyu, Lequita M Mayhew, Linda J Eason, Linh Tu, Lisa Hornback, Lorelei S Jarrell, Lori S Lawless, LT Melanie M Mayor, USPHS, Lynette P Salisbury, Mabel M Lee, Maida Henesian (NMI), Marcus A Ray, Margaret H Waters, Margaret Torres Vazquez, Marie K Kinkade, Mariza M Jafary, Marsha W Major, Martha T Olone, Maureen C Melvin, Merideth K Rose, Michael D Ellison, Michael D Robinson, Michael F Skelly, PhD, Michael Shanks, MS, Michael T Cyrus, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Mildred L Mccray, Min Shanmabel Liu, Mohamad A Chahine, Monique Rac Lester, Natasha A Dezinna, Nayan J Patel, Nebil A Oumer, Nicholas F Lyons, Nicholas L Hunt, Nicholas Obiri, PhD, Nicole J Clausen, Nicole K Trudel, Nicole S Williams, Nina D Patel, Norman Fogg, Norman K Starks, Norman Wong, Omotunde O Osunsanmi, Patricia A Morrow, Patrick C Klotzbuecher, Paula J Bretz, Peter E Baker, Peter Kessler, PhD, Philip J Snoy, Philip W Beck, Prabhu P Raju, Rachel C Harrington, Rafael Padilla, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Regina Gibson Melton, Richard Heath Coats, Riley C Myers, PhD, Rina Bhikha, Robert D Tollefsen, Robert L Hummel, Robert L Stevenson, Roberta W Cunningham, Roberto A Dookhan, Rose Ashley, Russell K Riley, Sandra S Saniga, Sarah B Tanksley, Scott N Lim, Serge L Beaucage, Sheilyn H Huang, Shelley H Beausoleil, Sherri J Jackson, Shusheen A Alexander, Sidney B Priesmeyer, Slatten, Stacey A Priest, Stephanie A Slater, MS, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephen D Eich, Steven P Donald, Stuart W Russell, Susan A Zullo, PhD, Susan M Jackson, Tamara Brey, Tamara N Champion, Tamika E Allen, RN, Thea C Grome, Theresa M Smedley, Thuy T Nguyen, LCDR, Timothy C Grome, Timothy M Albright, Todd M Stankewicz, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Valerie G Vallely, Walden H Lee, Wayne L Jefferson, William D Bassett, Jr, William D Murray, William V Millar, Yi Wang, PhD, Young M Yoon, Zhongren Wu

Lakisha M Williams's Documents

Publish Date Document Type Title
June, 2008 FDA 483 Mercy Medical Center IRB - Form 483, 2008-06-24
July, 2010 EIR Genentech, Inc. - EIR, 2010-07-16
February, 2009 FDA 483 BioReliance Corporation - Form 483, 2009-02-18
December, 2010 FDA 483 Abbott Laboratories - Form 483, 2010-12-16
April, 2009 FDA 483 BASi Gaithersburg, LLC - Form 483, 2009-04-22
December, 2010 EIR Abbott Laboratories - EIR, 2010-12-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more